PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
10-Apr-2023 Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers Creative Diagnostics
07-Apr-2023 CD Bioparticles Launches mRNA Transfection Reagents for Research Applications CD Bioparticles
05-Apr-2023 CluePoints Announces Amit Patel as New CFO CluePoints
04-Apr-2023 BioSenic appoints Lieven Huysse, MD, as Chief Medical Officer BioSenic
03-Apr-2023 EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases EBViously
30-Mar-2023 Clinical Study of TISSIUM’s COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in Australia TISSIUM
30-Mar-2023 Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development Modus Therapeutics
30-Mar-2023 AlzeCure presents new data at Alzheimer’s conference AD/PD on the potential disease-modifying effect of NeuroRestore ACD856 AlzeCure
30-Mar-2023 Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer Immutep
30-Mar-2023 AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases Asklepios BioPharmaceutical, Inc
30-Mar-2023 Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need Galimedix Therapeutics
30-Mar-2023 Evonik underpins leading position in drug delivery for RNA therapeutics with start of construction of new U.S. facility for pharmaceutical lipids Evonik
30-Mar-2023 NRG Therapeutics Announces International Scientific Advisory Board NRG Therapeutics
30-Mar-2023 Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Trobix Bio
30-Mar-2023 Molecure Announces Full Year Financial 2022 Results – A Year of Significant Progress Molecure S.A.
29-Mar-2023 Suppliers’ supply chain and continuous manufacturing are the big risk & resilience issues for US CDMOs De Facto Communications
28-Mar-2023 InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health InfanDx
28-Mar-2023 Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001 Thermosome
27-Mar-2023 U.S. Burn AI Clinical Training Study Enrollment Completed STIFEL
27-Mar-2023 U.S. Burn AI Clinical Training Study Enrollment Completed” WH Ireland Capital Markets